Back to Search Start Over

CD34 immunostaining for microvascular invasion analysis in hepatocelullar carcinoma

Authors :
Paulo Henrique Costa Diniz
Henrique Valladao Pires Gama
Ronniel Morais Albuquerque
David Campos Wanderley
Marcelo Xavier
Fernanda Maria Farage Osorio
Claudia Alves Couto
Teresa Cristina de Abreu Ferrari
Agnaldo Soares Lima
Gabriela Freitas Chaves
Paula Vieira Teixeira Vidigal
Source :
Journal of Clinical Oncology. 41:609-609
Publication Year :
2023
Publisher :
American Society of Clinical Oncology (ASCO), 2023.

Abstract

609 Background: Hepatocellular carcinoma is the most common primary neoplasia of the liver. Microvascular invasion predicts outcome and defines tumor staging. However, its diagnosis is still a challenge. The present study aims to evaluate inter and intraobserver agreement in identifying the presence of microvascular invasion using conventional and immunohistochemistry histology. Methods: Three pathologists performed the analysis of 76 hepatocellular carcinoma explants to characterize the presence of microvascular invasion using the hematoxylin/eosin stain and immunohistochemistry for CD34. The evaluations were made individually, in two distinct moments. Results were analyzed by the Kappa’s coefficient and ROC curves. Results: Our study demonstrated similar agreement for microvascular invasion between hematoxylin/eosin and CD34 methods. However, the intraobserver agreement values for both methods were higher than the interobserver ones. The accuracy of CD34 in relation to hematoxylin/eosin by ROC curves in intraobserver analysis tends to a high specificity, ranging from 82.1 to almost 100%, with sensitivity of 46.9 to 81.1%. In interobserver analysis, CD34 also has a high specificity (84.3 to 85.5%) while its sensitivity is a little shorter (81.2 to 84.3%). Conclusions: Intraobserver higher agreement allows us to suppose that pathologists employed own criteria to evaluate vascular invasion, reinforcing the need of standardization. ROC Curves analysis showed that the CD34 method is more specific than sensitive. Therefore, immunohistochemistry for CD34 should not be used routinely, but it could be useful to help confirming invasion previously seen by conventional histology.

Subjects

Subjects :
Cancer Research
Oncology

Details

ISSN :
15277755 and 0732183X
Volume :
41
Database :
OpenAIRE
Journal :
Journal of Clinical Oncology
Accession number :
edsair.doi...........77481d31275255096e5a787bba72f1f2
Full Text :
https://doi.org/10.1200/jco.2023.41.4_suppl.609